Katalog
Hilfe
Bauen Sie hier Ihr Portfolio auf
Geben Sie die Menge neben den benötigten Aktien ein – Ihr Portfolio wird automatisch erstellt.
Schneller Screener: nach Kategorie und Empfehlung filtern, Fundamentaldaten, Kennzahlen und Unternehmensprofile überprüfen.
| Unternehmen | Kategorie | Preis | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Stil | Horizont | Pot. | Risiko | Empfehlung | Portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | Pharma | 103.37 | -1.79% | 2.7% | 1.3% | 3.60 | -2.6% | 0.0% | Ausgewogen | Mittel | 57 | 60 | Halten |
|
| AbbVie (ABBV) | Pharma | 254.98 | +1.59% | 3.7% | 1.3% | 2.04 | -9.7% | 2.3% | Wachstum | Mittel | 69 | 43 | Halten |
|
| Amneal Pharmaceuticals (AMRX) | Pharma | 16.87 | -2.20% | 0.0% | 1.2% | 0.50 | 10.2% | 34.8% | Wert | Mittel | 65 | 50 | Kaufen |
|
| Amphastar Pharmaceuticals (AMPH) | Pharma | 23.54 | +2.17% | 0.0% | 1.4% | 1.74 | 7.4% | 46.8% | Wert | Mittel | 72 | 34 | Kaufen |
|
| AstraZeneca (AZN) | Pharma | 159.64 | +1.72% | 2.1% | 1.3% | 6.72 | 0.6% | 2.4% | Wachstum | Mittel | 41 | 70 | Verkaufen |
|
| Avadel Pharmaceuticals (AVDL) | Pharma | 21.64 | 0.00% | 0.0% | 0.0% | 0.00 | 13.7% | -162.5% | Wachstum | Mittel | 39 | 70 | Verkaufen |
|
| Bausch Health (BHC) | Pharma | 6.07 | -1.46% | 0.0% | 2.8% | -2.95 | 13.0% | 31.3% | Wachstum | Mittel | 44 | 70 | Verkaufen |
|
| Bayer (BAYRY) | Pharma | 14.07 | -1.68% | 0.2% | 1.0% | -0.42 | -20.2% | 26.1% | Wachstum | Mittel | 36 | 70 | Verkaufen |
|
| Centessa Pharmaceuticals (CNTA) | Pharma | 40.50 | 0.00% | 93.8% | 0.0% | -1.78 | 0.0% | -36.8% | Wachstum | Mittel | 30 | 71 | Verkaufen |
|
| Compass Pathways (CMPS) | Pharma | 14.22 | -6.26% | 0.0% | 3.6% | -5.57 | 0.0% | -308.7% | Wachstum | Mittel | 70 | 80 | Halten |
|
| CoreSite (COR) | Pharma | 320.95 | -0.73% | 0.7% | 1.1% | 13.52 | 8.2% | 3.0% | Wachstum | Mittel | 63 | 40 | Kaufen |
|
| Dr. Reddy's Laboratories (RDY) | Pharma | 11.71 | -1.43% | 0.7% | 0.6% | 39.83 | 6.4% | -34.7% | Wert | Mittel | 30 | 70 | Verkaufen |
|
| Eli Lilly (LLY) | Pharma | 1123.04 | -0.10% | 0.6% | 1.8% | 29.85 | 16.0% | 30.9% | Wachstum | Lang | 60 | 70 | Halten |
|
| Gilead Sciences (GILD) | Pharma | 144.81 | -0.58% | 3.2% | 1.5% | 7.42 | -12.2% | 6.3% | Wachstum | Mittel | 62 | 48 | Kaufen |
|
| GSK (GSK) | Pharma | 48.12 | -1.05% | 3.6% | 1.4% | 2.40 | 10.2% | 7.1% | Wachstum | Mittel | 42 | 69 | Verkaufen |
|
| Incyte (INCY) | Pharma | 123.28 | -2.17% | 0.0% | 1.6% | 8.13 | 31.5% | 43.7% | Wachstum | Mittel | 71 | 38 | Kaufen |
|
| Johnson & Johnson (JNJ) | Pharma | 266.35 | -0.27% | 2.3% | 1.2% | 8.67 | -2.0% | 0.7% | Ausgewogen | Mittel | 71 | 36 | Kaufen |
|
| Ligand Pharmaceuticals (LGND) | Pharma | 289.25 | +0.42% | 0.0% | 1.1% | 10.01 | 23.1% | 17.9% | Wachstum | Mittel | 70 | 40 | Kaufen |
|
| Merck (MRK) | Pharma | 144.71 | -1.96% | 2.8% | 3.1% | 1.26 | 2.0% | 51.9% | Wachstum | Lang | 79 | 34 | Kaufen |
|
| Moderna (MRNA) | Pharma | 136.62 | +0.74% | 0.0% | 39.5% | -7.98 | -62.7% | 60.9% | Wachstum | Mittel | 41 | 73 | Verkaufen |
|
| Novartis (NVS) | Pharma | 137.48 | 0.00% | 4.1% | 3.6% | 7.02 | 1.4% | 2.0% | Wachstum | Lang | 40 | 72 | Verkaufen |
|
| Novo Nordisk (NVO) | Pharma | 44.01 | -1.23% | 4.3% | 1.8% | 27.45 | 22.3% | 11.1% | Wachstum | Mittel | 66 | 37 | Kaufen |
|
| Organon & Co (OGN) | Pharma | 13.63 | -0.29% | 0.6% | 0.1% | 0.79 | 6.7% | -54.9% | Wachstum | Mittel | 44 | 63 | Halten |
|
| Pfizer (PFE) | Pharma | 27.65 | -0.47% | 6.2% | 1.4% | 0.76 | 4.0% | 3.9% | Wachstum | Mittel | 62 | 40 | Kaufen |
|
| Revolution Medicines (RVMD) | Pharma | 203.35 | -2.08% | 0.0% | 2.0% | -8.86 | 0.0% | -50.0% | Wachstum | Mittel | 37 | 70 | Verkaufen |
|
| Roche (RHHBY) | Pharma | 53.19 | -0.36% | 2.9% | 1.9% | 2.84 | 2.3% | 5.1% | Wachstum | Lang | 62 | 39 | Kaufen |
|
| Sanofi (SNY) | Pharma | 42.72 | -0.30% | 5.6% | 1.0% | 0.48 | 9.4% | 10.0% | Wert | Mittel | 45 | 70 | Verkaufen |
|
| Teva Pharmaceutical Industries (TEVA) | Pharma | 36.35 | -1.36% | 0.0% | 1.7% | 0.63 | 4.0% | -75.0% | Ausgewogen | Mittel | 65 | 65 | Halten |
|
| Vertex Pharmaceuticals (VRTX) | Pharma | 514.56 | -1.26% | 0.0% | 1.7% | 17.32 | 11.6% | -0.2% | Wachstum | Mittel | 63 | 60 | Halten |
|
| Viatris (VTRS) | Pharma | 16.38 | -0.73% | 3.4% | 1.2% | -0.26 | -5.0% | 7.1% | Ausgewogen | Mittel | 52 | 65 | Halten |
|